JEFFERIES ON ENTERO HEALTHCARE ; BUY | TARGET ₹2,100 (EARLIER ₹1,800)

• Targets 23% FY27 revenue growth, with potential upside from acquisitions. • Expects 20% revenue CAGR and EBITDA margins above 6% over three years. • MedTech expansion, organic growth and working capital efficiency support profitability.

ENTERO HEALTHCARE SOLU L

← Back to feed